Comparison Overview

Hetero Drugs Ltd

VS

Parexel

Hetero Drugs Ltd

India Hyderabad, 500018, IN
Last Update: 2025-12-09
Between 750 and 799

Hetero is a research based global pharmaceutical company focused on development, manufacturing and marketing of Active Pharmaceutical Ingredients (APIs), Intermediate Chemicals & Finished Dosages. Ever since its establishment in 1993, Hetero showed a tradition of excellence and deep sense of commitment in developing cost effective processes to offer wide range of affordable drugs.

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 10,001
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Parexel

541 Church at North Hills St, 1000, Raleigh, North Carolina, US, 27609
Last Update: 2025-12-09
Between 750 and 799

Parexel is among the world’s largest clinical research organizations (CROs), providing the full range of Phase I to IV clinical development services to help life-saving treatments reach patients faster. Leveraging the breadth of our clinical, regulatory and therapeutic expertise, our team of more than 21,000 global professionals collaborates with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind, increasing access and participation to make clinical research a care option for anyone, anywhere. Our depth of industry knowledge and strong track record gained over the past 40 years is moving the industry forward and advancing clinical research in healthcare’s most complex areas, while our innovation ecosystem offers the best solutions to make every phase of the clinical trial process more efficient. With the people, insight and focus on operational excellence, we work every day to treat patients with dignity and continuously learn from their experiences, so every trial makes a difference. For more information, visit parexel.com. Community Guidelines Because Parexel’s social media channels are open to the general public and employees, we are not responsible for views expressed other than our own. However, we do not tolerate posts that are: • Abusive, harassing or threatening to others. • Defamatory, offensive, obscene, vulgar or depicting violence. • Hateful targeting by race/ethnicity, age, color, creed, religion, gender, sexual preference or orientation, nationality or political beliefs. • Sexually explicit or pornographic. • Fraudulent, deceptive, libelous, misleading or unlawful. • Referencing criminal or illegal activity. • Spamming. We reserve the right to remove any comments that do not adhere to our guidelines as well as report users who violate the rules of our page.

NAICS: 3254
NAICS Definition: Pharmaceutical and Medicine Manufacturing
Employees: 20,504
Subsidiaries: 0
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Badges Comparison

Security & Compliance Standards Overview

https://images.rankiteo.com/companyimages/hetero-drugs-ltd.jpeg
Hetero Drugs Ltd
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
https://images.rankiteo.com/companyimages/parexel.jpeg
Parexel
ISO 27001
ISO 27001 certification not verified
Not verified
SOC2 Type 1
SOC2 Type 1 certification not verified
Not verified
SOC2 Type 2
SOC2 Type 2 certification not verified
Not verified
GDPR
GDPR certification not verified
Not verified
PCI DSS
PCI DSS certification not verified
Not verified
HIPAA
HIPAA certification not verified
Not verified
Compliance Summary
Hetero Drugs Ltd
100%
Compliance Rate
0/4 Standards Verified
Parexel
0%
Compliance Rate
0/4 Standards Verified

Benchmark & Cyber Underwriting Signals

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Hetero Drugs Ltd in 2025.

Incidents vs Pharmaceutical Manufacturing Industry Average (This Year)

No incidents recorded for Parexel in 2025.

Incident History — Hetero Drugs Ltd (X = Date, Y = Severity)

Hetero Drugs Ltd cyber incidents detection timeline including parent company and subsidiaries

Incident History — Parexel (X = Date, Y = Severity)

Parexel cyber incidents detection timeline including parent company and subsidiaries

Notable Incidents

Last 3 Security & Risk Events by Company

https://images.rankiteo.com/companyimages/hetero-drugs-ltd.jpeg
Hetero Drugs Ltd
Incidents

No Incident

https://images.rankiteo.com/companyimages/parexel.jpeg
Parexel
Incidents

No Incident

FAQ

Parexel company demonstrates a stronger AI Cybersecurity Score compared to Hetero Drugs Ltd company, reflecting its advanced cybersecurity posture governance and monitoring frameworks.

Historically, Parexel company has disclosed a higher number of cyber incidents compared to Hetero Drugs Ltd company.

In the current year, Parexel company and Hetero Drugs Ltd company have not reported any cyber incidents.

Neither Parexel company nor Hetero Drugs Ltd company has reported experiencing a ransomware attack publicly.

Neither Parexel company nor Hetero Drugs Ltd company has reported experiencing a data breach publicly.

Neither Parexel company nor Hetero Drugs Ltd company has reported experiencing targeted cyberattacks publicly.

Neither Hetero Drugs Ltd company nor Parexel company has reported experiencing or disclosing vulnerabilities publicly.

Neither Hetero Drugs Ltd nor Parexel holds any compliance certifications.

Neither company holds any compliance certifications.

Neither Hetero Drugs Ltd company nor Parexel company has publicly disclosed detailed information about the number of their subsidiaries.

Parexel company employs more people globally than Hetero Drugs Ltd company, reflecting its scale as a Pharmaceutical Manufacturing.

Neither Hetero Drugs Ltd nor Parexel holds SOC 2 Type 1 certification.

Neither Hetero Drugs Ltd nor Parexel holds SOC 2 Type 2 certification.

Neither Hetero Drugs Ltd nor Parexel holds ISO 27001 certification.

Neither Hetero Drugs Ltd nor Parexel holds PCI DSS certification.

Neither Hetero Drugs Ltd nor Parexel holds HIPAA certification.

Neither Hetero Drugs Ltd nor Parexel holds GDPR certification.

Latest Global CVEs (Not Company-Specific)

Description

PCSX2 is a free and open-source PlayStation 2 (PS2) emulator. In versions 2.5.377 and below, an unchecked offset and size used in a memcpy operation inside PCSX2's CDVD SCMD 0x91 and SCMD 0x8F handlers allow a specially crafted disc image or ELF to cause an out-of-bounds read from emulator memory. Because the offset and size is controlled through MG header fields, a specially crafted ELF can read data beyond the bounds of mg_buffer and have it reflected back into emulated memory. This issue is fixed in version 2.5.378.

Risk Information
cvss4
Base: 5.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:L/VI:N/VA:L/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

Aircompressor is a library with ports of the Snappy, LZO, LZ4, and Zstandard compression algorithms to Java. In versions 3.3 and below, incorrect handling of malformed data in Java-based decompressor implementations for Snappy and LZ4 allow remote attackers to read previous buffer contents via crafted compressed input. With certain crafted compressed inputs, elements from the output buffer can end up in the uncompressed output, potentially leaking sensitive data. This is relevant for applications that reuse the same output buffer to uncompress multiple inputs. This can be the case of a web server that allocates a fix-sized buffer for performance purposes. There is similar vulnerability in GHSA-cmp6-m4wj-q63q. This issue is fixed in version 3.4.

Risk Information
cvss4
Base: 6.3
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:P/PR:N/UI:N/VC:L/VI:N/VA:N/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A vulnerability was found in itsourcecode COVID Tracking System 1.0. Affected by this vulnerability is an unknown functionality of the file /admin/?page=zone. The manipulation of the argument ID results in sql injection. The attack may be launched remotely. The exploit has been made public and could be used.

Risk Information
cvss2
Base: 7.5
Severity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
cvss3
Base: 7.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A vulnerability has been found in itsourcecode COVID Tracking System 1.0. Affected is an unknown function of the file /admin/login.php of the component Admin Login. The manipulation of the argument Username leads to sql injection. The attack may be initiated remotely. The exploit has been disclosed to the public and may be used.

Risk Information
cvss2
Base: 7.5
Severity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
cvss3
Base: 7.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X
Description

A flaw has been found in campcodes Online Student Enrollment System 1.0. This impacts an unknown function of the file /admin/register.php. Executing manipulation of the argument photo can lead to unrestricted upload. The attack can be launched remotely. The exploit has been published and may be used.

Risk Information
cvss2
Base: 7.5
Severity: LOW
AV:N/AC:L/Au:N/C:P/I:P/A:P
cvss3
Base: 7.3
Severity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:L
cvss4
Base: 6.9
Severity: LOW
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:L/SC:N/SI:N/SA:N/E:P/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X